Literature DB >> 21121853

Colchicine's other indication--effect of FDA action.

Wayne W Grody, Terri Getzug.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21121853     DOI： 10.1056/NEJMc1009918

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.

Authors:  Aaron S Kesselheim; Jessica M Franklin; Seoyoung C Kim; John D Seeger; Daniel H Solomon
Journal:  J Gen Intern Med       Date:  2015-04-09       Impact factor: 5.128

2.  Microtubules underlie dysfunction in duchenne muscular dystrophy.

Authors:  Ramzi J Khairallah; Guoli Shi; Francesca Sbrana; Benjamin L Prosser; Carlos Borroto; Mark J Mazaitis; Eric P Hoffman; Anup Mahurkar; Fredrick Sachs; Yezhou Sun; Yi-Wen Chen; Roberto Raiteri; W Jonathan Lederer; Susan G Dorsey; Christopher W Ward
Journal:  Sci Signal       Date:  2012-08-07       Impact factor: 8.192

Review 3.  Unintended effects of orphan product designation for rare neurological diseases.

Authors:  Sinéad M Murphy; Araya Puwanant; Robert C Griggs
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

4.  The prevalence and cost of unapproved uses of top-selling orphan drugs.

Authors:  Aaron S Kesselheim; Jessica A Myers; Daniel H Solomon; Wolfgang C Winkelmayer; Raisa Levin; Jerry Avorn
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.